Consultancy (part-time) to assist in the development of target product profiles (TPPs) for treatments addressing AMR priority pathogens

BACKGROUND

The department of Essential Medicines and Health Products (EMP) works with Member States and partners to improve access to essential medicines and other health products, including assistive products, and to promote rational use. Antimicrobial resistance (AMR) is a global public health challenge. For the priority pathogens identified, WHO is committed to developing TPPs for treatments against infections caused by priority AMR pathogens on the basis of a WHO harmonized methodology on TPPs development and in consultation with key stakeholders in the public health and scientific communities.

Purpose of the work:

The purpose of the Request for Proposal (RFP) is to select a suitable contractor to carry out the following work: 

The purpose of the consultancy is to assist the WHO Innovation Access and Use (IAU) Unit in the development of target product profiles (TPPs) for treatments addressing antimicrobial resistance (AMR) priority pathogens. Working closely with the WHO IAU unit, and with input from technical partners, the consultant`s role will be to prepare background documentation on TPPs for AMR priority pathogens, develop and draft the TPPs and support the management of experts meetings and inputs related to the development of the TPPs following an agreed WHO methodology.

Work to be performed:

Please see fully attached ToR.

Planned timelines:

Start date:  15/10/2018

End date: 14/10/2019

Key requirements for this assignment:

Experience:

•               Capacity to interact with technical experts in public health organizations, governments, academia, and industry with respect to R&D for diagnostics and therapeutics;

•               Knowledge and experience in therapeutics research and development including development of target product profiles; and

•               Knowledge and experience from working on AMR related issues.

Qualifications and experience required:    

•               Master’s degree in a health-related field;

•               At least 7 years of relevant professional experience working in the field of therapeutics research and development - with specific experience in antibiotics and in R&D targeted towards use in low and middle income countries; and

•               Experience working with multiple stakeholders, including health authorities, academic institutions and industry.

Desirable:

Experience in working for WHO, other UN organizations and programmes or similar institutions.

Language requirement

•               English – proficient (reading, writing, speaking)

•               French - intermediate knowledge (desirable)

Additional information:

The implementation of the assignment may require international travel; costs for such travel will be borne by WHO according to its rules and regulations. The contractor has to be legally entitled to work in the country or countries where the work is to be carried out, and is expected to be in the possession of an unrestricted passport.

Submission of proposals:

No later than  20 September 2018 (17:00 CET),the bidder shall complete and return by email to WHO (only when this step is completed the bidder is regarded as a prospective bidder) a proposal and a CV of the respective consultant with the following:

Financial proposal including number of working days in 2018 and 2019 (maximum can be 80) and the proposal should be indicated clearly by daily rate.

A prospective bidder requiring any clarification on technical, contractual or commercial matters may notify WHO via email at the following address no later than 5 days prior to the closing date for the submission of offers:

Email for submissions of forms and proposal:       iauinfo@who.int

(use subject: Bid Ref HQ/EMP/2018/013)

Refer to attached documents for additional information.